ABT
2026Q2BMOAbbott Laboratories primary · HEALTHCARE · MEDICAL DEVICES
Street
Consensus EPS1.28
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move4.5%
IV front—
P/C full—
P/C front—
Features as of2026-07-15
Run-up
Close—
Ret 5d-6.2%
Ret 10d-1.6%
Ret 20d+0.7%
Ret 30d+1.7%
Actual EPS
1.31Beat
Estimated EPS1.28
Actual revenue
12.6B
Surprise %+2.3%
Beat / missBeat
Beat streak 41
Beat streak 81
Reaction
1-day stock reaction+3.7%
Implied vs actual
Implied 4.5%Actual 6.7%
Gap reaction+6.7%
Day result+10.7%
Next-day upYes
Realized / IV1.50×
Post tape
Post 5d+1.9%
Post 10d+6.9%
Post volume32.8M
Vol ×10d2.82×
Vol ×20d2.39×
Post range7.2%